SCHEMBL2406834

SCHEMBL2406834

CNC(=O)c1cc2occc2[nH]1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 2/20 0.65
▸ POLB P06746 1/20 0.54
▸ GAA P10253 1/20 0.50
▸ ALOX15 P16050 2/20 0.49
▸ PTPN11 Q06124 1/20 0.42
▸ NTRK1 P04629 1/20 0.41
▸ KMT2A Q03164 1/20 0.38
▸ NUDT1 P36639 2/20 0.38
▸ CREBBP Q92793 1/20 0.38
▸ SMYD3 Q9H7B4 2/20 0.36
▸ CHEK1 O14757 1/20 0.36
▸ RET P07949 1/20 0.36
▸ PDGFRB P09619 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ PDGFRA P16234 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ RPS6KA3 P51812 1/20 0.36
▸ LIMK1 P53667 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ TYRO3 Q06418 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12904066 0.85 DAO (0.67) DAOPOLBGAAALOX15NTRK1
SCHEMBL12880134 0.83 DAO (0.59) DAOPOLBGAAALOX15NTRK1
SCHEMBL12864395 0.81 DAO (0.71) DAOPOLBGAANTRK1KMT2A
SCHEMBL13319927 0.80 DAO (0.56) DAOPOLBGAAALOX15KMT2A
SCHEMBL13319926 0.80 DAO (0.56) DAOPOLBGAAALOX15NTRK1
SCHEMBL989408 0.80 DAO (0.65) DAOPOLBGAACREBBP
SCHEMBL679809 0.79 DAO (1.00) DAOPOLBGAAALOX15KMT2A
SCHEMBL17883341 0.78 DAO (0.62) DAOPOLBGAAPTPN11
SCHEMBL12904065 0.78 DAO (0.62) DAOPOLBGAAALOX15
SCHEMBL12904064 0.78 DAO (0.58) DAOPOLBGAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551864-A Substituted tricyclic amides, analogs thereof, and methods of using the same 爱彼特生物制药公司 2022-12-30 — — CN disclosed
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-09-01 — — US disclosed
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, AOC1 DAO 2/4885POLB 2437/4885GAA 1237/4885
US-20110212969-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC10, HDAC1 DAO 2452/4885POLB 539/4885GAA 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback